股票 › EOLS
艾沃鲁斯 EOLS
美股市值排名 #3695
$6.81 +$0.01 (+0.15%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $6.81 0.00%
开盘$6.74
昨收$6.80
当日区间$6.57 – $6.92
成交量1.52M
市值$450.41M
市盈率(TTM)–
股息率–
股权结构与仓位
谁在持有、谁在做空,以及大资金的流向
机构持股比例77.1%+4.00 个百分点,较上季度
持仓机构数186+1 ,较上季度
内部人近期交易28次买入 / 22次卖出净买入
空头持仓比例9.70% 占流通股回补天数 7.1 · 截至 15 Oct 2026
卖空成交量占比24.4%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入,近20个交易日
大单买入减卖出的净额(美元)。该窗口期内:−$83.4K(9个净流入日,11个净流出日)。
按单量净流入,近20个交易日
超大单/大单近似机构级别交易;中单/小单近似散户级别交易。各档买入减卖出净额,按窗口期累计。
已披露的前五大股东合计持有35.6%的流通股。
最大股东
按投资者类型
过去6次双周报告中(31 Jul 2026至15 Oct 2026),空头持仓占流通股比例已从8.46%升至9.70%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Pinnacle Associates, Ltd. | Mutual Fund | 2026/Q3 | +82,797 | 2.4% |
| Soleus Capital Management, L.P. | Hedge Fund | 2026/Q3 | +2,657,572 | 5.3% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +101,383 | 0.2% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q3 | +1,508,518 | 2.3% |
| Perceptive Advisors LLC | VC/PE Fund | 2026/Q3 | +1,172,423 | 3.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +550,445 | 7.3% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +376,504 | 2.6% |
| Pinnacle Associates, Ltd. | Mutual Fund | 2026/Q3 | +328,369 | 2.3% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +326,770 | 2.7% |
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +310,035 | 1.4% |
| Walleye Capital LLC | Hedge Fund | 2026/Q3 | +253,817 | 0.4% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +227,056 | 2.4% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +169,934 | 0.3% |
| KPV Capital Advisors, LP | Hedge Fund | 2026/Q3 | +150,000 | 0.2% |
| Teachers Insurance and Annuity Association-College Retirement Equities Fund | Mutual Fund | 2026/Q3 | +122,012 | 0.3% |
按报告期列出的机构买卖动态,变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 1 Sep 2026 | David Moatazedi | Chief Executive Officer | Open Market Disposition | -105,108 | $9.04 | 361 |
| 19 Mar 2026 | Rui Avelar | Chief Medical Officer and Head of Research & Development | Automatic Disposition | -3,119 | $4.75 | 272,662 |
| 19 Mar 2026 | David Moatazedi | Chief Executive Officer | Automatic Disposition | -13,669 | $4.75 | 105,469 |
| 16 Mar 2026 | Rui Avelar | Chief Medical Officer and Head of Research & Development | Automatic Disposition | -21,192 | $4.89 | 275,781 |
| 16 Mar 2026 | David Moatazedi | Chief Executive Officer | Automatic Disposition | -49,231 | $4.89 | 119,138 |
| 16 Mar 2026 | Rui Avelar | Chief Medical Officer and Head of Research & Development | Derivative Exercise and Sale | -8,804 | $4.89 | 275,781 |
| 16 Mar 2026 | David Moatazedi | Chief Executive Officer | Derivative Exercise and Sale | -67,489 | $4.89 | 119,138 |
| 16 Feb 2026 | David Gill | Independent Director | Other Acquisition | +45,559 | – | 52,923 |
| 16 Feb 2026 | Rui Avelar | Chief Medical Officer and Head of Research & Development | Other Acquisition | +94,913 | – | 160,705 |
| 16 Feb 2026 | Rui Avelar | Chief Medical Officer and Head of Research & Development | Other Derivative Acquisition | +94,913 | – | 94,913 |
| 16 Feb 2026 | Rui Avelar | Chief Medical Officer and Head of Research & Development | Other Derivative Acquisition | +138,649 | $4.39 | 138,649 |
| 16 Feb 2026 | Albert White | Independent Director | Other Acquisition | +45,559 | – | 64,430 |
| 16 Feb 2026 | Vikram Malik | Independent Chairperson | Other Acquisition | +45,559 | – | 52,923 |
| 16 Feb 2026 | Karah Parschauer | Independent Director | Other Acquisition | +45,559 | – | 52,923 |
| 16 Feb 2026 | David Moatazedi | Chief Executive Officer | Other Acquisition | +313,212 | – | 523,081 |
| 16 Feb 2026 | David Moatazedi | Chief Executive Officer | Other Derivative Acquisition | +457,541 | $4.39 | 457,541 |
| 16 Feb 2026 | David Moatazedi | Chief Executive Officer | Other Derivative Acquisition | +626,424 | – | 626,424 |
| 16 Feb 2026 | Brady Stewart | Independent Director | Other Acquisition | +45,559 | – | 52,923 |
| 16 Feb 2026 | Tatjana Mitchell | Chief Financial Officer | Other Acquisition | +121,489 | – | 226,092 |
| 16 Feb 2026 | Tatjana Mitchell | Chief Financial Officer | Other Derivative Acquisition | +121,489 | – | 121,489 |
数据来自Form 4/Form 144申报文件。负数为减持(出售、赠予或代扣税款股份),正数为增持。
空头持仓(按报告期)
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 6,408,688 | 9.7% | 7.1 |
| 30 Sep 2026 | 5,628,168 | 8.5% | 9.3 |
| 15 Sep 2026 | 5,530,759 | 8.4% | 6.6 |
| 31 Aug 2026 | 5,368,957 | 8.1% | 5.2 |
| 14 Aug 2026 | 5,853,655 | 8.9% | 4.4 |
| 31 Jul 2026 | 5,568,442 | 8.5% | 8.7 |
暂无评论——快来第一个聊聊 EOLS。
登录后参与讨论。